Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01806129 · ClinicalTrials.gov registry record · NA
Reproductive Health Program in Patients With Cancer
A NA study of Malignant Neoplasm, sponsored by ECOG-ACRIN Cancer Research Group.
- Active
- Registry status
- NA
- Development phase
- 434
- Enrollment target
- 20
- Study locations
NCT01806129 is a NA study of Malignant Neoplasm that is active but no longer recruiting, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 434 participants, below the 506-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (14% lower). The trial reports 20 study locations across 5 states.
The verdict
NCT01806129, a NA study of Malignant Neoplasm, is active but no longer recruiting, sponsored by ECOG-ACRIN Cancer Research Group.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 434 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical trial studies reproductive health program in patients with cancer. A reproductive health program may improve patients' understanding of reproductive risks and receipt of appropriate treatment to achieve their reproductive health goals.
Conditions Studied
Interventions
- OTHER Standard practice related to reproductive heath
- OTHER Training modules, algorithm, referral development
Study Locations (20)
Hawaii
- Hawaii Cancer Care Inc-POB II - Honolulu
- Queen's Cancer Cenrer - POB I - Honolulu
- Queen's Medical Center - Honolulu
- Straub Clinic and Hospital - Honolulu
- University of Hawaii Cancer Center - Honolulu
- Queen's Cancer Center - Kuakini - Honolulu
- Kapiolani Medical Center for Women and Children - Honolulu
- Tripler Army Medical Center - Honolulu
- Pali Momi Medical Center - ‘Aiea
Colorado
- Rocky Mountain Cancer Centers-Aurora - Aurora
- Rocky Mountain Cancer Centers-Boulder - Boulder
- Cancer Center of Colorado at Sloan's Lake - Denver
- Rocky Mountain Cancer Centers-Sky Ridge - Lone Tree
- SCL Health Lutheran Medical Center - Wheat Ridge
Illinois
- John H Stroger Jr Hospital of Cook County - Chicago
- Carle on Vermilion - Danville
- Carle Physician Group-Effingham - Effingham
Georgia
- Augusta University Medical Center - Augusta
- John B Amos Cancer Center - Columbus
Arkansas
- Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro - Jonesboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 434 participants |
| Start Date | 2016-09-02 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01806129
The ClinicalTrials.gov registry entry for NCT01806129 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 434 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 506-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (14% lower). The listed sponsor is ECOG-ACRIN Cancer Research Group, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Standard practice related to reproductive heath is the first listed.
NCT01806129 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Hawaii, Colorado, Illinois.
Frequently Asked Questions
What is clinical trial NCT01806129 about?
NCT01806129 is a clinical study titled "Reproductive Health Program in Patients With Cancer". This clinical trial studies reproductive health program in patients with cancer. A reproductive health program may improve patients' understanding of reproductive risks and receipt of appropriate treatment to achieve their reproductive health goals.
What is the current status of trial NCT01806129?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 434 participants. The study started on 2016-09-02. Estimated completion is 2025-12-30.
What conditions does trial NCT01806129 study?
This clinical trial studies the following conditions: Malignant Neoplasm.
What interventions are being tested in trial NCT01806129?
The interventions under investigation include: Standard practice related to reproductive heath (OTHER), Training modules, algorithm, referral development (OTHER).
Who is sponsoring clinical trial NCT01806129?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01806129 being conducted?
This trial has 20 study locations across Arkansas, Colorado, Georgia, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
RECRUITING · NA
-
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
RECRUITING · NA
-
Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.